Replies to post #2495 on Zynerba Pharmaceuticals (ZYNE)

[Amatuer17]

Thanks

Your concern is valid in terms of buyout - if FX results are as good as phase 2, this stock can cross $20 easily as it translates into market cap of $500 million and this is pivotal.

This also confirms the MOA in CNS and also ASD - this can fly and GWPH can offer $30 easily and I will not be happy.

Just for ASD, this is $ 1.0 B market cap stock. I am ready to wait for 1-2 years for that.

[Amatuer17]

From company presentation

“ As of now, our timelines for delivery of top line results from all of our ongoing trials remain unchanged

• Includes our expectation of results from our pivotal CONNECT-FX trial in FXS late in late June 2020”

Tomorrow is last day of Jun - will we get good news tomorrow?